Information on insider transactions in PAXMAN AB (publ)

PAXMAN AB (publ) announces that the company’s two largest shareholders, Glenn Paxman and Björn Littorin, have sold 250,000 shares each in the company, i.e. 500,000 shares in total. The shares were acquired by Länsförsäkringar Blekinge, Länsförsäkringar Kalmar län and a limited number of private, long-term investors. Glenn Paxman now owns 6,538,645 shares in PAXMAN, and Björn Littorin owns 1,035,076 shares.

As a result of the transaction, Länsförsäkringar Blekinge and Länsförsäkringar Kalmar län now strengthen their positions as two of the company’s ten largest shareholders.

The transaction was conducted outside the market after trading hours on July 2nd at a price of SEK 23.50 per share. 

For further information, please contact:
Richard Paxman, CEO
Tel: +44 7968 020641
E-mail: richard@paxmanscalpcooling.com
www.paxmanscalpcooling.com

About PAXMAN
The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With more than 3,000 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK) and Houston, Texas (US)

The PAXMAN share is listed on Nasdaq First North. FNCA Sweden AB is the company’s Certified Adviser.